Securing retatrutide in the United States currently presents a challenge as it's not yet approved for widespread commercial sale . Doctors participating in investigational studies may be prescribing it, but access is restricted to those enrolled. Independent pharmacies , operating under specific permits , *might* offer compounded versions, but puri